- Home
- FHTX vs WNC Comparison
FHTX vs WNC Comparison
Compare FHTX & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FHTX | WNC |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.4M | 325.8M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | FHTX | WNC |
|---|---|---|
| Price | $5.40 | $12.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $11.50 | $11.00 |
| AVG Volume (30 Days) | 376.3K | ★ 884.1K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 3.84% |
| EPS Growth | 25.32 | ★ 179.22 |
| EPS | ★ N/A | N/A |
| Revenue | $30,909,000.00 | ★ $2,027,489,000.00 |
| Revenue This Year | $8.89 | $10.65 |
| Revenue Next Year | $20.13 | $14.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.75 | 8.81 |
| 52 Week Low | $3.27 | $6.63 |
| 52 Week High | $6.95 | $14.32 |
Technical Indicators
Market Signals| Indicator | FHTX | WNC |
|---|---|---|
| Relative Strength Index (RSI) | 60.26 | 59.90 |
| Support Level | $5.22 | $8.34 |
| Resistance Level | $5.70 | $12.94 |
| Average True Range (ATR) | 0.48 | 0.67 |
| MACD | 0.05 | -0.17 |
| Stochastic Oscillator | 57.15 | 42.73 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.